Page last updated: 2024-08-16

resveratrol and cyc 202

resveratrol has been researched along with cyc 202 in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Kramer, MP; Maurer, M; Wesierska-Gadek, J1
Komina, O; Wesierska-Gadek, J1
Kramer, MP; Wesierska-Gadek, J1

Other Studies

5 other study(ies) available for resveratrol and cyc 202

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Resveratrol modulates roscovitine-mediated cell cycle arrest of human MCF-7 breast cancer cells.
    Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2008, Volume: 46, Issue:4

    Topics: Antineoplastic Agents; Antioxidants; Breast Neoplasms; Cell Count; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA; Female; Flow Cytometry; Humans; Purines; Resveratrol; Roscovitine; Stilbenes

2008
Action of resveratrol alone or in combination with roscovitine, a CDK inhibitor, on cell cycle progression in human HL-60 leukemia cells.
    Biochemical pharmacology, 2008, Dec-01, Volume: 76, Issue:11

    Topics: Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; Cyclin-Dependent Kinases; Flow Cytometry; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Phosphorylation; Protein Kinase Inhibitors; Purines; Resveratrol; Roscovitine; Stilbenes

2008
Monitoring of long-term effects of resveratrol on cell cycle progression of human HeLa cells after administration of a single dose.
    Annals of the New York Academy of Sciences, 2009, Volume: 1171

    Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinases; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Synergism; Flow Cytometry; HeLa Cells; Humans; Protein Kinase Inhibitors; Purines; Resveratrol; Ribonucleotide Reductases; Roscovitine; Stilbenes; Time Factors

2009